Formulation and Evaluation of New Glimepiride Sublingual Tablets. (5th February 2017)

• Record Type: Journal Article
• Authors: Al-Madhagi, Wafa; Abdulbari Albarakani, Ahmed; Khaled Alhag, Abobakr; Ahmed Saeed, Zakaria; Mansour Noman, Nahlah; Mohamed, Khaldon
• Other Names: Flores-Murrieta Francisco Javier Academic Editor.
• Is Part Of: Journal of pharmaceutics. Volume 2017(2017)
• Publication Date: 2017-02-05
• Subjects: Pharmaceutical industry -- Periodicals; Drug Industry; Technology, Pharmaceutical; Pharmaceutical industry; Periodicals; 615.1
• DOI: 10.1155/2017/3690473
• Languages: English
• ISSNs: 2090-9918

Abstract

Abstract : Oral mucosal delivery of drugs promotes rapid absorption and high bioavailability, with a subsequent immediate onset of pharmacological effect. However, many oral mucosal deliveries are compromised by the possibility of the patient swallowing the active substance before it has been released and absorbed locally into the systemic circulation. The aim of this research was to introduce a new glimepiride formula for sublingual administration and rapid drug absorption that can be used in an emergency. The new sublingual formulation was prepared after five trials to prepare the suitable formulation. Two accepted formulations of the new sublingual product were prepared, but one of them with disintegration time of 1.45 min and searching for preferred formulation, the binder, is changed with Flulac and starch slurry to prepare formula with disintegration time of 21 seconds that supports the aim of research to be used in an emergency. The five formulations were done, after adjusting to the binder as Flulac and aerosil with disintegration time of 21 seconds and accepted hardness as well as the weight variation. The assay of a new product (subglimepiride) is 103% which is a promising result, confirming that the formula succeeded. The new product (subglimepiride) is accepted in most quality control tests and it is ready for marketing.